Related Experiment Video
Updated: Feb 16, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Chronic kidney disease severely deteriorates the outcome of gastrointestinal bleeding: A meta-analysis
Roland Hágendorn1, Nelli Farkas2, Áron Vincze1
1Department of Gastroenterology, First Department of Medicine, University of Pécs, Pécs 7624, Hungary.
Insights
Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) face higher mortality, rebleeding rates, and transfusion needs when experiencing gastrointestinal (GI) bleeding. Further research is essential to improve outcomes for these vulnerable patients.
Area of Science:
- Nephrology
- Gastroenterology
- Clinical Research
Background:
- Gastrointestinal (GI) bleeding is a common clinical emergency.
- Chronic kidney disease (CKD) and end-stage renal disease (ESRD) are prevalent conditions that may affect GI bleeding outcomes.
- Limited data exist on the specific impact of renal impairment on GI bleeding prognosis.
Purpose of the Study:
- To evaluate the influence of CKD and ESRD on mortality, transfusion requirements, and rebleeding rates in patients with GI bleeding.
- To assess the impact of renal disease on length of hospitalization for GI bleeding.
Main Methods:
- A systematic literature search was performed across EMBASE, PubMed, and Cochrane databases.
- Included studies reported on GI bleeding patients with CKD or ESRD and their outcomes.
- Meta-analysis was conducted using Comprehensive Meta-Analysis software with random effects models.
Main Results:
- Analysis of 6 studies (406,035 patients) revealed significantly higher mortality in CKD (OR=1.786) and ESRD (OR=2.530) groups.
- Patients with impaired renal function experienced increased rebleeding rates (OR=2.510).
- CKD patients required more red blood cell transfusions (MD=1.863) and had longer hospital stays (MD=13.245).
Conclusions:
- ESRD significantly increases mortality, transfusion needs, rebleeding rates, and length of hospitalization in GI bleeding patients.
- CKD also adversely affects these outcomes.
- Prospective patient registries and observational clinical trials are needed to further elucidate these findings.
Aim:
To understand the influence of chronic kidney disease (CKD) on mortality, need for transfusion and rebleeding in gastrointestinal (GI) bleeding patients.
Methods:
A systematic search was conducted in three databases for studies on GI bleeding patients with CKD or end-stage renal disease (ESRD) with data on outcomes of mortality, transfusion requirement, rebleeding rate and length of hospitalization (LOH). Calculations were performed with Comprehensive Meta-Analysis software using the random effects model. Heterogeneity was tested by using Cochrane's Q and I2 statistics. Mean difference (MD) and OR (odds ratio) were calculated.
Results:
1063 articles (EMBASE: 589; PubMed: 459; Cochrane: 15) were found in total. 5 retrospective articles and 1 prospective study were available for analysis. These 6 articles contained data on 406035 patients, of whom 51315 had impaired renal function. The analysis showed a higher mortality in the CKD group (OR = 1.786, 95%CI: 1.689-1.888, P < 0.001) and the ESRD group (OR = 2.530, 95%CI: 1.386-4.616, P = 0.002), and a rebleeding rate (OR = 2.510, 95%CI: 1.521-4.144, P < 0.001) in patients with impaired renal function. CKD patients required more unit red blood cell transfusion (MD = 1.863, 95%CI: 0.812-2.915, P < 0.001) and spent more time in hospital (MD = 13.245, 95%CI: 6.886-19.623, P < 0.001) than the controls.
Conclusion:
ESRD increases mortality, need for transfusion, rebleeding rate and LOH among GI bleeding patients. Prospective patient registries and observational clinical trials are crucially needed.
More Related Videos
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Mortar Joint Deterioration in Masonry
The...